TRAVERE THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
TRAVERE THERAPEUTICS, INC. (TVTX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $9.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $3.08M, a 39.79% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $6.38M, a 282.16% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$446.00K.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.33M, a 56.42% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $7.66M, a 142.04% increase from fiscal 2024.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $3.16M, a 32.06% decline from fiscal 2023.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $4.66M, a 10.37% decline from fiscal 2022.
- TRAVERE THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $5.20M, a 261.08% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 34 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $9.46M 10-Q · filed 2026-08-04 | $9.01M derived: sum of 3 quarters · filed 2026-08-04 | $10.34M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2026-03-31 | $6.38M 10-Q · filed 2026-05-04 | $5.94M derived: sum of 2 quarters · filed 2026-05-04 | $7.26M derived: sum of 3 quarters · filed 2026-05-04 | $12.37M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-12-31 | -$446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $881.00K derived: sum of 2 quarters · filed 2026-02-19 | $5.99M derived: sum of 3 quarters · filed 2026-08-04 | $7.66M 10-K · filed 2026-02-19 | |||||
| 2025-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $6.43M derived: sum of 2 quarters · filed 2026-08-04 | $8.10M 10-Q · filed 2025-10-30 | $6.37M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-06-30 | $5.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.78M 10-Q · filed 2026-08-04 | $5.04M derived: sum of 3 quarters · filed 2026-08-04 | $8.08M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-03-31 | $1.67M 10-Q · filed 2026-05-04 | -$69.00K derived: sum of 2 quarters · filed 2026-05-04 | $2.98M derived: sum of 3 quarters · filed 2026-05-04 | $2.11M derived: sum of 4 quarters · filed 2026-05-04 | |||||
| 2024-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.31M derived: sum of 2 quarters · filed 2026-02-19 | $440.00K derived: sum of 3 quarters · filed 2026-02-19 | $3.16M 10-K · filed 2026-02-19 | |||||
| 2024-09-30 | $3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.18M derived: sum of 2 quarters · filed 2025-10-30 | $4.90M 10-Q · filed 2025-10-30 | $5.16M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2024-06-30 | -$866.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.86M 10-Q · filed 2025-08-06 | $2.11M derived: sum of 3 quarters · filed 2026-02-19 | $6.97M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2024-03-31 | $2.72M 10-Q · filed 2025-05-01 | $2.98M derived: sum of 2 quarters · filed 2026-02-19 | $7.83M derived: sum of 3 quarters · filed 2026-02-19 | $4.78M derived: sum of 4 quarters · filed 2026-02-19 | |||||
| 2023-12-31 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.11M derived: sum of 2 quarters · filed 2026-02-19 | $2.06M derived: sum of 3 quarters · filed 2026-02-19 | $4.66M 10-K · filed 2026-02-19 | |||||
| 2023-09-30 | $4.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.80M derived: sum of 2 quarters · filed 2024-10-31 | $4.40M 10-Q · filed 2024-10-31 | $7.00M derived: sum of 4 quarters · filed 2025-02-21 | |||||
| 2023-06-30 | -$3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$452.00K 10-Q · filed 2024-08-01 | -$933.00K 10-Q · filed 2023-08-03 | $2.15M derived: sum of 3 quarters · filed 2025-02-21 | $2.41M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $2.60M 10-Q · filed 2024-05-06 | $2.35M 10-Q · filed 2023-05-04 | $5.20M derived: sum of 2 quarters · filed 2025-02-21 | $5.46M derived: sum of 3 quarters · filed 2025-02-21 | $8.44M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $2.86M derived: sum of 2 quarters · filed 2025-02-21 | $5.84M derived: sum of 3 quarters · filed 2025-02-21 | $5.20M 10-K · filed 2025-02-21 | $4.91M 10-K · filed 2023-02-23 | ||||
| 2022-09-30 | $257.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.24M derived: sum of 2 quarters · filed 2023-11-07 | $2.59M 10-Q · filed 2023-11-07 | $1.56M 10-Q · filed 2022-10-27 | $1.99M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $2.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.34M 10-Q · filed 2023-08-03 | $2.20M 10-Q · filed 2022-08-04 | $1.73M derived: sum of 3 quarters · filed 2024-02-20 | $2.55M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | -$648.00K 10-Q · filed 2023-05-04 | -$1.25M derived: sum of 2 quarters · filed 2024-02-20 | -$433.00K derived: sum of 3 quarters · filed 2024-02-20 | $303.00K derived: sum of 4 quarters · filed 2024-02-20 | |||||
| 2021-12-31 | -$606.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $215.00K derived: sum of 2 quarters · filed 2024-02-20 | $951.00K derived: sum of 3 quarters · filed 2024-02-20 | $1.44M 10-K · filed 2024-02-20 | $1.44M 10-K · filed 2022-02-24 | ||||
| 2021-09-30 | $821.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $1.56M derived: sum of 2 quarters · filed 2022-10-27 | $2.04M 10-Q · filed 2022-10-27 | ||||||
| 2021-06-30 | $736.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.22M 10-Q · filed 2022-08-04 | |||||||
| 2021-03-31 | $488.00K 10-Q · filed 2022-05-05 | ||||||||
| 2020-12-31 | $4.31M 10-K · filed 2023-02-23 | ||||||||
| 2019-12-31 | -$208.00K 10-K · filed 2022-02-24 | $7.93M 10-K · filed 2020-02-24 | |||||||
| 2018-12-31 | $1.36M 10-K · filed 2021-03-01 | ||||||||
| 2017-12-31 | $2.70M 10-K · filed 2020-02-24 | ||||||||
| 2017-03-31 | $944.00K 10-Q · filed 2017-05-05 | $2.57M derived: sum of 2 quarters · filed 2019-02-26 | $2.19M derived: sum of 3 quarters · filed 2019-02-26 | $2.38M derived: sum of 4 quarters · filed 2019-02-26 | |||||
| 2016-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.25M derived: sum of 2 quarters · filed 2019-02-26 | $1.43M derived: sum of 3 quarters · filed 2019-02-26 | $2.45M 10-K · filed 2019-02-26 | |||||
| 2016-09-30 | -$375.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$191.00K derived: sum of 2 quarters · filed 2016-11-04 | $822.00K 10-Q · filed 2016-11-04 | -$124.00K derived: sum of 4 quarters · filed 2018-07-06 | |||||
| 2016-06-30 | $184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.20M 10-Q · filed 2016-08-05 | $251.00K derived: sum of 3 quarters · filed 2018-07-06 | $1.74M derived: sum of 4 quarters · filed 2018-07-06 | |||||
| 2016-03-31 | $1.01M 10-Q · filed 2017-05-05 | $67.00K derived: sum of 2 quarters · filed 2018-07-06 | $1.56M derived: sum of 3 quarters · filed 2018-07-06 | $2.11M derived: sum of 4 quarters · filed 2018-07-06 | |||||
| 2015-12-31 | -$946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-06 | $546.00K derived: sum of 2 quarters · filed 2018-07-06 | $1.09M derived: sum of 3 quarters · filed 2018-07-06 | $966.00K 10-K · filed 2018-07-06 | |||||
| 2015-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $2.04M derived: sum of 2 quarters · filed 2016-11-04 | $1.91M 10-Q · filed 2016-11-04 | $1.71M 10-Q · filed 2015-11-06 | $433.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $547.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $420.00K 10-Q · filed 2016-08-05 | -$138.00K 10-Q · filed 2015-08-10 | -$1.06M derived: sum of 3 quarters · filed 2017-03-01 | -$631.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | -$127.00K 10-Q · filed 2016-05-05 | -$127.39K 10-Q · filed 2015-05-11 | -$1.61M derived: sum of 2 quarters · filed 2017-03-01 | -$1.18M derived: sum of 3 quarters · filed 2017-03-01 | $98.86K derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$1.05M derived: sum of 2 quarters · filed 2017-03-01 | $225.86K derived: sum of 3 quarters · filed 2017-03-01 | -$237.00K 10-K · filed 2017-03-01 | -$237.13K 10-K · filed 2015-03-11 | ||||
| 2014-09-30 | $428.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.70M derived: sum of 2 quarters · filed 2015-11-06 | $1.24M 10-Q · filed 2015-11-06 | $1.24M 10-Q · filed 2014-11-13 | $2.13M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $814.00K 10-Q · filed 2015-08-10 | $1.70M derived: sum of 3 quarters · filed 2016-02-26 | ||||||
| 2014-03-31 | -$462.86K 10-Q · filed 2015-05-11 | $427.32K derived: sum of 2 quarters · filed 2016-02-26 | |||||||
| 2013-12-31 | $890.18K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $1.35M 10-K · filed 2016-02-26 | $1.35M 10-K · filed 2014-03-28 | $1.37M 10-K/A · filed 2015-07-09 | |||||
| 2013-09-30 | $458.82K 10-Q · filed 2014-11-13 | ||||||||
| 2012-12-31 | $14.83K 10-K/A · filed 2015-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |